Colour enhancement

From PsychonautWiki
(Redirected from Color enhancement)
Jump to navigation Jump to search

Colour enhancement is defined as an intensification of the brightness and vividness of colors in the external environment. During this experience, reds may seem “redder”, greens may seem “greener", and all colors will likely appear much more distinct, complex, and visually intense than they comparatively would be during everyday sober living.[1][2][3][4][5][6][7][8] At higher levels, this effect can sometimes result in seeing colours which are perceived as surreal or seemingly impossible.[3][4]

Colour enhancement is often accompanied by other coinciding effects such as acuity enhancement and pattern recognition enhancement.[1][2] It is most commonly induced under the influence of mild dosages of psychedelic compounds, such as LSD, psilocybin, and mescaline. However, it can also occur to a lesser extent under the influence of certain stimulants and dissociatives such as MDMA, ketamine[9], or 3-MeO-PCP.

Image examples

 Caption
5-Hydroxytryptophan
4-AcO-MiPT
25I-NBOMe
3-MeO-PCE
25B-NBOH
2C-D
4-HO-DET
25I-NBOH
DOI
4-AcO-DiPT
25C-NBOH
Experience:800 seeds LSA - My First Trip Ever
Aniracetam
Paradise island by Xanny.jpgParadise island by Subsentience
Experience:4.5g - The Grand Introduction to Beauty and Fear
MiPT
4-FA
DOC
Experience:3 Grams of Mushrooms - Reset on my Life, Experiencing Satori and the Cosmic Perspective
MDA
Experience:75mg 3-FMA - Perfect Blend of Euphoria and Functionality
Experience:A combination of DOC, 5-MAPB, 5-MeO-DMT, ETH-LAD, Cannabis, Pentedrone
DOB
Phenylpiracetam
Experience:BK-2C-B - Various experiences
4-AcO-DET
Experience:1mg 25c-NBOMe - Experiment in my room
ALD-52
5-MeO-DiPT
3-MMC
Phenethylamine (compound)
Experience:300µg LSD - Togetherness and the Silent Dusk
4-HO-EPT
Experience:225mg Pregabalin +Cannabis -Bliss and Serenity; a hedonistic evening
1B-LSD
Ibogaine
Coluracetam
LSA
JWH-018
2C-I
Cannabis
GABAergic hallucinogens
THJ-2201
Psilocin
Oxiracetam
4-HO-MiPT
Chur City in Switzerland.jpgChur, Switzerland by Naps284
Experience:300µg AL-LAD - Don't worry, because you're everyone!
DPT
4-HO-MET
TMA-6
Escaline
2C-T-2
THJ-018
Methallylescaline
Experience:2 tabs DOB - My DOB Nightmare
MET
Experience:1000 Morning Glory seeds - Rediscovering the Self
5F-PB-22
MPT
Experience:150mg MDMA + 20mg 2C-B - I designed it this way myself
PRO-LAD
25N-NBOMe
2C-E
Experience: 5-EAPB (60mg) + 2-FMA (20mg) + 4-AcO-DMT (10mg) - Emotional catharsis
Experience:4-HO-MiPT / A care free psychedelic getaway
Proscaline
2C-P
Experience:Mushrooms and Snuff Films -- Trip Report (3.5 grams)
DET
DiPT
2C-C
PARGY-LAD
2C-H
Experience:Unknown Dose DOC (Insufflated) - Overdosing and Terifying Ego Death
5-MeO-DALT
Enhancement of colours - woods.jpgThe Woods by Chelsea Morgan
2C-B
2C-T-21
LSD
Βk-2C-B
Efavirenz
TMA-2
Experience:120mg - Garden of The Gods
Pramiracetam
Amanita muscaria
Chameleon.jpgChameleon by Anonymous.
Experience: 36mg 4-AcO-DiPT - Truly, one for the psychedelic animals among us
DOM
4-HO-DiPT
Experience:3g mimosa / 3g syrian rue - Connecting with my body
MDMA
Omberacetam
LSZ
AL-LAD
Experience:300mg DXM + 25mg DMT + Cannabis - A crazy night
4-HO-MPT
Ayahuasca
Allylescaline
4-AcO-DMT
Enhancement of colour rose.jpgRose by Chelsea Morgan
Experience:25mg Deschloroketamine - My first time orally dosing DCK
6-APDB
Experience:337mg DMT fumarate - A Day With DMT
LSM-775
4-AcO-MET
5-MeO-MiPT
Experience:Unknown dosage / 1 tab DOC - Psychedelia Turned Into Stimulant Psychosis
Experience:2C-P (approx. 35mg) - Asymmetrical Terror and the Geometric Sea
1P-LSD
Memantine
5-MeO-DiBF
Experience:40mg - Brothermind and the Forest's Hand
MDAI
Psilocybin mushrooms
25B-NBOMe
Experience:250mg DXM - DXM Itch and Trip Report
MIPLA
6-APB
25C-NBOMe
Experience:5.3g psilocybe cubensis - Dimensional Circumstance and the Fabric of Understanding
DMT
Experience: 15mg 2C-B (oral) - A pleasant low-dose evening with Nexus
Experience:60mg 4-AcO-DMT Nonstop Quasi-Orgasmic Objectless Euphoria
Experience:225ug LSD + 9g cubensis - Galactic Melt and the Meverse
25D-NBOMe
EPT
Bromo-DragonFLY
Piracetam
Bufotenin
Experience:3.5g psilocybe cubensis - Relinquishing of Material Chains/Fear and Desolation
Pregabalin
Tree.jpgJapanese Garden by Anonymous
2C-B-FLY
Mescaline
1P-ETH-LAD
Enhancementofcolour.jpgShowing differences by Chelsea Morgan
Selective serotonin reuptake inhibitor
4-HO-DPT
Experience:25mg 3-MeO-PCP - Enhanced film experience
Experience:4x 200ug tabs - You do not need to understand
Experience: 22mg 2C-B (oral) / 100ug 1P-LSD (sublingual) - My first time tripping alone (2 days in a row)
Experience:3-MeO-PCP - Extreme psychosis
MDEA
3C-E
ΑMT
2C-T-7
ETH-LAD
Experience:2.5g Syrian rue + 6g Mimosa Hostilis - Becoming God (my second experience with unity)

Psychoactive substances

Compounds within our psychoactive substance index which may cause this effect include:

... further results

Experience reports

Annectdotal reports which describe this effect with our experience index include:

See also

External links

References

  1. 1.0 1.1 Papoutsis, Ioannis; Nikolaou, Panagiota; Stefanidou, Maria; Spiliopoulou, Chara; Athanaselis, Sotiris (2014). "25B-NBOMe and its precursor 2C-B: modern trends and hidden dangers". Forensic Toxicology. 33 (1): 1–11. doi:10.1007/s11419-014-0242-9. ISSN 1860-8965. 
  2. 2.0 2.1 Bersani, Francesco Saverio; Corazza, Ornella; Albano, Gabriella; Valeriani, Giuseppe; Santacroce, Rita; Bolzan Mariotti Posocco, Flaminia; Cinosi, Eduardo; Simonato, Pierluigi; Martinotti, Giovanni; Bersani, Giuseppe; Schifano, Fabrizio (2014). "25C-NBOMe: Preliminary Data on Pharmacology, Psychoactive Effects, and Toxicity of a New Potent and Dangerous Hallucinogenic Drug". BioMed Research International. 2014: 1–6. doi:10.1155/2014/734749. ISSN 2314-6133. 
  3. 3.0 3.1 Hartman, Alan M.; Hollister, Leo E. (1963). "Effect of mescaline, lysergic acid diethylamide and psilocybin on color perception". Psychopharmacologia. 4 (6): 441–451. doi:10.1007/BF00403349. ISSN 0033-3158. 
  4. 4.0 4.1 Kleinman, J. E.; Gillin, J. C.; Wyatt, R. J. (1977). "A Comparison of the Phenomenology of Hallucinogens and Schizophrenia From Some Autobiographical Accounts*". Schizophrenia Bulletin. 3 (4): 560–586. doi:10.1093/schbul/3.4.560. ISSN 0586-7614. 
  5. . doi:10.3389/Ffnhum.2015.00346.  Missing or empty |title= (help)
  6. Obreshkova, D., Kandilarov, I., Angelova, V. T., Iliev, Y., Atanasov, P., & Fotev, P. S. (2017). PHARMACO-TOXICOLOGICAL ASPECTS AND ANALYSIS OF PHENYLALKYLAMINE AND INDOLYLALKYLAMINE HALLUCINOGENS (REVIEW). PHARMACIA, 64(1), 41-42. http://bsphs.org/wp-content/uploads/2017/04/Angelova.pdf
  7. Abraham, Henry David (1983). "Visual Phenomenology of the LSD Flashback". Archives of General Psychiatry. 40 (8): 884. doi:10.1001/archpsyc.1983.01790070074009. ISSN 0003-990X. 
  8. Baggott, M.J.; Coyle, J.R.; Erowid, E.; Erowid, F.; Robertson, L.C. (2011). "Abnormal visual experiences in individuals with histories of hallucinogen use: A web-based questionnaire". Drug and Alcohol Dependence. 114 (1): 61–67. doi:10.1016/j.drugalcdep.2010.09.006. ISSN 0376-8716. 
  9. Dillon, P (2003). "Patterns of use and harms associated with non-medical ketamine use". Drug and Alcohol Dependence. 69 (1): 23–28. doi:10.1016/S0376-8716(02)00243-0. ISSN 0376-8716.